FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.4.11  |  FHIR Version n/a  User: [n/a]

Resource ValueSet/FHIR Server from package us.nlm.vsac#0.21.0 (78 ms)

Package us.nlm.vsac
Type ValueSet
Id Id
FHIR Version R4
Source http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113762.1.4.1196.158/expansion
Url http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158
Version 20190829
Status active
Date 2019-08-29T05:00:24-04:00
Name MultipleMyelomaRegimenDrugs
Title Multiple Myeloma Regimen Drugs
Experimental False
Realm us
Authority hl7
Description All drug components for the treatment of multiple myeloma across all regimens from NCCR 2019
Purpose (Clinical Focus: Multiple Myeloma chemo regimen drugs),(Data Element Scope: SCDGs only.),(Inclusion Criteria: All routed medication proxy for the specified regimen components (SCDG as a proxy for routed drug).),(Exclusion Criteria: None.)

Resources that use this resource

No resources found


Resources that this resource uses

CodeSystem
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm
http://www.nlm.nih.gov/research/umls/rxnorm RxNorm


Source

{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113762.1.4.1196.158",
  "meta" : {
    "versionId" : "6",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueContactDetail" : {
        "name" : "Elimu Informatics Author"
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-02-14"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2019-08-29"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1196.158",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113762.1.4.1196.158"
    }
  ],
  "version" : "20190829",
  "name" : "MultipleMyelomaRegimenDrugs",
  "title" : "Multiple Myeloma Regimen Drugs",
  "status" : "active",
  "experimental" : false,
  "date" : "2019-08-29T05:00:24-04:00",
  "publisher" : "Elimu Informatics Steward",
  "description" : "All drug components for the treatment of multiple myeloma across all regimens from NCCR 2019",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: Multiple Myeloma chemo regimen drugs),(Data Element Scope: SCDGs only.),(Inclusion Criteria: All routed medication proxy for the specified regimen components (SCDG as a proxy for routed drug).),(Exclusion Criteria: None.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "filter" : [
          {
            "property" : "concept",
            "op" : "in",
            "value" : "1154535,1154531"
          }
        ]
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "filter" : [
          {
            "property" : "concept",
            "op" : "in",
            "value" : "1154535,1154531,1163075,1156182,1160774,1302968,1721949,1160009,1726108,1369715"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:d66bbc04-047f-4b94-9826-d140d921b582",
    "timestamp" : "2024-12-10T07:36:44-05:00",
    "total" : 10,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1154531",
        "display" : "dexamethasone Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1154535",
        "display" : "dexamethasone Oral Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1156182",
        "display" : "cyclophosphamide Oral Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1160009",
        "display" : "bendamustine Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1160774",
        "display" : "doxorubicin Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1163075",
        "display" : "bortezomib Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1302968",
        "display" : "carfilzomib Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1369715",
        "display" : "pomalidomide Oral Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1721949",
        "display" : "daratumumab Injectable Product"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "11042024",
        "code" : "1726108",
        "display" : "elotuzumab Injectable Product"
      }
    ]
  },
  "text" : {
  }
}

XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.